<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>Proteome Science - Latest articles</title>
		<link>http://www.proteomesci.com</link>
		<description>The latest articles from Proteome Science (ISSN 1477-5956) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/26"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/25"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/24"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/23"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/22"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/21"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/20"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/19"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/18"/>			    
            
				    <rdf:li rdf:resource="http://www.proteomesci.com/content/6/1/17"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.proteomesci.com/content/6/1/26">
            
            <title>Multidimensional protein fractionation using ProteomeLab PF 2D&#8482; for profiling amyotrophic lateral sclerosis immunity: A preliminary report</title>
			<description>Background:
The ProteomeLab&#8482; PF 2D platform is a relatively new approach to global protein profiling. Herein, it was used for investigation of plasma proteome changes in amyotrophic lateral sclerosis (ALS) patients before and during immunization with glatiramer acetate (GA) in a clinical trial.
Results:
The experimental design included immunoaffinity depletion of 12 most abundant proteins from plasma samples with the ProteomeLab&#8482; IgY-12 LC10 column kit as first dimension separation, also referred to as immuno-partitioning. Second and third dimension separations of the enriched proteome were performed on the PF 2D platform utilizing 2D isoelectric focusing and RP-HPLC with the resulting fractions collected for analysis. 1D gel electrophoresis was added as a fourth dimension when sufficient protein was available. Protein identification from collected fractions was performed using nano-LC-MS/MS approach. Analysis of differences in the resulting two-dimensional maps of fractions obtained from the PF 2D and the ability to identify proteins from these fractions allowed sensitivity threshold measurements. Masked proteins in the PF 2D fractions are discussed.
Conclusion:
We offer some insight into the strengths and limitations of this emerging proteomic platform.</description>
			<link>http://www.proteomesci.com/content/6/1/26</link>
			
			 	<dc:creator>Joshua D Schlautman, Wojciech Rozek, Robert Stetler, R Lee Mosley, Howard E Gendelman and Pawel Ciborowski</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:26</dc:source>
			<dc:date>2008-09-12</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-26</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>26</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/25">
            
            <title>A simple and reliable protocol for mouse serum proteome profiling studies by use of two-dimensional electrophoresis and MALDI TOF/TOF mass spectrometry</title>
			<description>Background:
Unravelling the serum proteome is the subject of intensified research. In this regard, two-dimensional electrophoresis coupled with MALDI MS analysis is still one of the most commonly used method. Despite some improvements, there is the need for better protocols to enable comprehensive identification of serum proteins.Here we report a combination of two proteomic strategies, zoom in acidic and neutral part of 2-D gels and an application of two optimised matrix preparations for MALDI-MS analyses to simplify serum proteome mapping.
Results:
Mouse serum proteins were separated by 2-D electrophoresis at the pH ranges 3&#8211;10 and 4&#8211;7, respectively. Then in gel tryptic digests were analysed by MALDI-MS. Notably, sample-matrix preparations consisted of either a thin-layer &#945;-ciano-4-hydroxycinnamic acid (CHCA) matrix deposition or a matrix-layer 2,5-dihydroxybenzoic acid (DHB). This enabled an identification of 90 proteins. The herein reported method enhanced identification of proteins by 32% when compared with previously published studies of mouse serum proteins, using the same approaches. Furthermore, experimental improvements of matrix preparations enabled automatic identification of mouse proteins, even when one of the two matrices failed.
Conclusion:
We report a simple and reliable protocol for serum proteome analysis that combines an optimized resolution of 2-D gels spots and improved sample-matrix preparations for MALDI-MS analysis. The protocol allowed automated data acquisition for both CHCA and DHB and simplified the MS data acquisition therefore avoiding time-consuming procedures. The simplicity and reliability of the developed protocol may be applied universally.</description>
			<link>http://www.proteomesci.com/content/6/1/25</link>
			
			 	<dc:creator>Maria Stella Ritorto and J&#252;rgen Borlak</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:25</dc:source>
			<dc:date>2008-09-12</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-25</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>25</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/24">
            
            <title>Trypanosoma cruzi alkaline 2-DE: Optimization and application to comparative proteome analysis of flagellate life stages</title>
			<description>Background:
Trypanosoma cruzi, a flagellate protozoan, is the etiological agent of Chagas disease, a chronic illness that causes irreversible damage to heart and digestive tract in humans. Previous 2-DE analyses of T. cruzi proteome have not focused on basic proteins, possibly because of inherent difficulties for optimizing 2-DE in the alkaline pH range. However, T. cruzi wide pH range 2-DE gels have shown few visible spots in the alkaline region, indicating that the parasite either did not have an appreciable amount of alkaline proteins or that these proteins were underrepresented in the 2-DE gels.
Results:
Different IEF conditions using 6&#8211;11 pH gradient strips were tested for separation of T. cruzi alkaline proteins. The optimized methodology described here was performed using anodic "paper bridge" sample loading supplemented by increased concentration of DTT and Triton X-100 on Multiphor II (GE Healthcare) equipment and an electrode pad embedded in DTT- containing solution near the cathode in order to avoid depletion of reducing agent during IEF. Landmark proteins were identified by peptide mass fingerprinting allowing the production of an epimastigote 2-DE map. Most identified proteins corresponded to metabolic enzymes, especially those related to amino acid metabolism. The optimized 2-DE protocol was applied in combination with the "two-in-one gel" method to verify the relative expression of the identified proteins between samples from epimastigote and trypomastigote life stages.
Conclusion:
High resolution 2-DE gels of T. cruzi life forms were achieved using the optimized methodology and a partial epimastigote alkaline 2-DE map was built. Among 700 protein spots detected, 422 were alkaline with a pI above 7.0. The "two-in-one gel" method simplified the comparative analysis between T. cruzi life stages since it minimized variations in spot migration and silver-stained spot volumes. The comparative data were in agreement with biological traits of T. cruzi life forms and also corroborated previous T. cruzi proteomic studies. For instance, enzymes related to amino acid metabolism and dehydrogenases were more abundant in epimastigote 2-DE gel whilst trans-sialidase and a paraflagellar protein were found specifically in the trypomastigote 2-DE profile.</description>
			<link>http://www.proteomesci.com/content/6/1/24</link>
			
			 	<dc:creator>Adriana D Magalh&#227;es, S&#233;bastien Charneau, Jaime Paba, Rafael AP Gu&#233;rcio, Antonio RL Teixeira, Jaime M Santana, Marcelo V Sousa and Carlos AO Ricart</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:24</dc:source>
			<dc:date>2008-09-08</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-24</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>24</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/23">
            
            <title>The identification of disease-induced biomarkers in the urine of BSE infected cattle</title>
			<description>Background:
The bovine spongiform encephalopathy (BSE) epidemic and the emergence of a new human variant of Creutzfeldt-Jakob Disease (vCJD) have led to profound changes in the production and trade of agricultural goods. The rapid tests currently approved for BSE monitoring in slaughtered cattle are all based on the detection of the disease related isoform of the prion protein, PrPd, in brain tissue and consequently are only suitable for post-mortem diagnosis. Objectives: In instances such as assessing the health of breeding stock for export purposes where post-mortem testing is not an option, there is a demand for an ante-mortem test based on a matrix or body fluid that would permit easy access and repeated sampling. Urine and urine based analyses would meet these requirements.
Results:
Two dimensional differential gel eletrophoresis (2D-DIGE) and mass spectrometry analyses were used to identify proteins exhibiting differential abundance in the urine of BSE infected cattle and age matched controls over the course of the disease. Multivariate analyses of protein expression data identified a single protein able to discriminate, with 100% accuracy, control from infected samples. In addition, a subset of proteins were able to predict with 85% &#177; 13.2 accuracy the time post infection that the samples were collected.
Conclusion:
These results suggest that in principle it is possible to identify biomarkers in urine useful in the diagnosis, prognosis and monitoring of disease progression of transmissible spongiform encephalopathy diseases (TSEs).</description>
			<link>http://www.proteomesci.com/content/6/1/23</link>
			
			 	<dc:creator>Sharon LR Simon, Lise Lamoureux, Margot Plews, Michael Stobart, Jillian LeMaistre, Ute Ziegler, Catherine Graham, Stefanie Czub, Martin Groschup and J David Knox</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:23</dc:source>
			<dc:date>2008-09-05</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-23</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>23</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-09-05</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/22">
            
            <title>The sea urchin (Strongylocentrotus purpuratus) test and spine proteomes</title>
			<description>Background:
The organic matrix of biominerals plays an important role in biomineral formation and in determining biomineral properties. However, most components of biomineral matrices remain unknown at present. In sea urchin, which is an important model organism for developmental biology and biomineralization, only few matrix components have been identified and characterized at the protein level. The recent publication of the Strongylocentrotus purpuratus genome sequence rendered possible not only the identification of possible matrix proteins at the gene level, but also the direct identification of proteins contained in matrices of skeletal elements by in-depth, high-accuracy, proteomic analysis.
Results:
We identified 110 proteins as components of sea urchin test and spine organic matrix. Fourty of these proteins occurred in both compartments while others were unique to their respective compartment. More than 95% of the proteins were detected in sea urchin skeletal matrices for the first time. The most abundant protein in both matrices was the previously characterized spicule matrix protein SM50, but at least eight other members of this group, many of them only known as conceptual translation products previously, were identified by mass spectrometric sequence analysis of peptides derived from in vitro matrix degradation. The matrices also contained proteins implicated in biomineralization processes previously by inhibition studies using antibodies or specific enzyme inhibitors, such as matrix metalloproteases and members of the mesenchyme-specific MSP130 family. Other components were carbonic anhydrase, collagens, echinonectin, a &#945;2-macroglobulin-like protein and several proteins containing scavenger receptor cysteine-rich domains. A few possible signal transduction pathway components, such as GTP-binding proteins, a semaphorin and a possible tyrosine kinase were also identified.
Conclusion:
This report presents the most comprehensive list of sea urchin skeletal matrix proteins available at present. The complex mixture of proteins identified in matrices of the sea urchin skeleton may reflect many different aspects of the mineralization process. Because LC-MS/MS-based methods directly measures peptides our results validate many predicted genes and confirm the existence of the corresponding proteins. Considering the many newly identified matrix proteins, this proteomic study may serve as a road map for the further exploration of biomineralization processes in an important model organism.</description>
			<link>http://www.proteomesci.com/content/6/1/22</link>
			
			 	<dc:creator>Karlheinz Mann, Albert J Poustka and Matthias Mann</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:22</dc:source>
			<dc:date>2008-08-11</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-22</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>22</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-08-11</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/21">
            
            <title>Deciphering animal development through proteomics: requirements and prospects</title>
			<description>In recent years proteomic techniques have started to become very useful tools in a variety of model systems of developmental biology. Applications cover many different aspects of development, including the characterization of changes in the proteome during early embryonic stages. During early animal development the embryo becomes patterned through the temporally and spatially controlled activation of distinct sets of genes. Patterning information is then translated, from gastrulation onwards, into regional specific morphogenetic cell and tissue movements that give the embryo its characteristic shape. On the molecular level, patterning is the outcome of intercellular communication via signaling molecules and the local activation or repression of transcription factors. Genetic approaches have been used very successfully to elucidate the processes behind these events. Morphogenetic movements, on the other hand, have to be orchestrated through regional changes in the mechanical properties of cells. The molecular mechanisms that govern these changes have remained much more elusive, at least in part due to the fact that they are more under translational/posttranslational control than patterning events. However, recent studies indicate that proteomic approaches can provide the means to finally unravel the mechanisms that link patterning to the generation of embryonic form. To intensify research in this direction will require close collaboration between proteome scientists and developmental researchers. It is with this aim in mind that we first give an outline of the classical questions of patterning and morphogenesis. We then summarize the proteomic approaches that have been applied in developmental model systems and describe the pioneering studies that have been done to study morphogenesis. Finally we discuss current and future strategies that will allow characterizing the changes in the embryonic proteome and ultimately lead to a deeper understanding of the cellular mechanisms that govern the generation of embryonic form.</description>
			<link>http://www.proteomesci.com/content/6/1/21</link>
			
			 	<dc:creator>Wolfgang E Reintsch and Craig A Mandato</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:21</dc:source>
			<dc:date>2008-07-24</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-21</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/20">
            
            <title>Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma</title>
			<description>Background:
Acute-phase response involves the simultaneous altered expression of serum proteins in association to inflammation, infection, injury or malignancy. Studies of the acute-phase response usually involve determination of the levels of individual acute-phase serum proteins. In the present study, the acute-phase response of patients with epithelial (EOCa) and germ-line (GOCa) ovarian carcinoma was investigated using the gel-based proteomic approach, a technique which allowed the simultaneous assessment of the levels of the acute-phase serum high abundance proteins. Data obtained were validated using ELISA and immunostaining of biopsy samples.
Results:
Enhanced expression of clusterin (CLU), &#945;1-antitrypsin, haptoglobin and leucine rich glycoprotein was detected in all patients. However, the levels of &#945;1-antichymotrypsin (ACT) was only enhanced in EOCa patients, while patients with GOCa were typically characterized by elevated levels of ceruloplasmin but lower levels of &#945;2-HS glycoprotein. The enhanced expression of CLU in EOCa and GOCa patients and up-regulated expression of ACT specifically in EOCa patients were confirmed by ELISA. Immunohistochemical staining of biopsy samples of EOCa and GOCa patients demonstrated correlation of the acute-phase protein expression.
Conclusion:
Patients with EOCa and GOCa demonstrated distinctive aberrant expression of serum and tissue high abundance acute-phase proteins compared to negative control women.</description>
			<link>http://www.proteomesci.com/content/6/1/20</link>
			
			 	<dc:creator>Yeng Chen, Boon-Kiong Lim, Suat-Cheng Peh, Puteri Shafinaz Abdul-Rahman and Onn Haji Hashim</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:20</dc:source>
			<dc:date>2008-07-18</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-20</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-07-18</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/19">
            
            <title>Proteomic profiling of urine for the detection of colon cancer</title>
			<description>Background:
Colorectal cancer is the second most common cause of cancer related death in the developed world. To date, no blood or stool biomarkers with both high sensitivity and specificity for potentially curable early stage disease have been validated for clinical use. SELDI and MALDI profiling are being used increasingly to search for biomarkers in both blood and urine. Both techniques provide information predominantly on the low molecular weight proteome (&lt;15 kDa). There have been several reports that colorectal cancer is associated with changes in the serum proteome that are detectable by SELDI and we hypothesised that proteomic changes would also be detectable in urine.
Results:
We collected urine from 67 patients with colorectal cancer and 72 non-cancer control subjects, diluted to a constant protein concentration and generated MALDI and SELDI spectra. The intensities of 19 peaks differed significantly between cancer and non-cancer patients by both t-tests and after adjusting for confounders using multiple linear regressions. Logistic regression classifiers based on peak intensities identified colorectal cancer with up to 78% sensitivity at 87% specificity. We identified and independently quantified 3 of the discriminatory peaks using synthetic stable isotope peptides (an 1885 Da fragment of fibrinogen and hepcidin-20) or ELISA (&#946;2-microglobulin).
Conclusion:
Changes in the urine proteome may aid in the early detection of colorectal cancer.</description>
			<link>http://www.proteomesci.com/content/6/1/19</link>
			
			 	<dc:creator>Douglas G Ward, Stephen Nyangoma, Howard Joy, Emma Hamilton, Wenbin Wei, Chris Tselepis, Neil Steven, Michael JO Wakelam, Philip J Johnson, Tariq Ismail and Ashley Martin</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:19</dc:source>
			<dc:date>2008-06-16</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-19</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-16</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/18">
            
            <title>Identification of differentially expressed proteins in spontaneous thymic lymphomas from knockout mice with deletion of p53</title>
			<description>Background:
Knockout mice with a deletion of p53 spontaneously develop thymic lymphomas. Two cell lines (SM5 and SM7), established from two independent tumours, exhibited about fifty to seventy two-fold differentially expressed proteins compared to wild type thymocytes by two-dimensional gel electrophoresis (2D-PAGE).
Results:
Protein spots excised from 2D-PAGE gels, were subjected to in-gel tryptic digestion and identified by liquid chromatography &#8211; tandem mass spectrometry. A total of 47 protein spots were identified. Immunological verification was performed for several of the differentially regulated proteins where suitable antibodies could be obtained. Functional annotation clustering revealed similarities as well as differences between the tumours. Twelve proteins that changed similarly in both tumours included up-regulation of rho GDP-dissociation inhibitor 2, proteasome subunit &#945; type 3, transforming acidic coiled-coil containing protein 3, mitochondrial ornithine aminotransferase and epidermal fatty acid binding protein and down-regulation of adenylosuccinate synthetase, tubulin &#946;-3 chain, a 25 kDa actin fragment, proteasome subunit &#946; type 9, cofilin-1 and glia maturation factor &#947;.
Conclusion:
Some of the commonly differentially expressed proteins are also differentially expressed in other tumours and may be putative diagnostic and/or prognostic markers for lymphomas.</description>
			<link>http://www.proteomesci.com/content/6/1/18</link>
			
			 	<dc:creator>Bent Honor&#233;, S&#248;ren Buus and Mogens H Cla&#235;sson</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:18</dc:source>
			<dc:date>2008-06-10</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-18</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-10</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.proteomesci.com/content/6/1/17">
            
            <title>Protein profiling of the dimorphic, pathogenic fungus, Penicillium marneffei</title>
			<description>Background:
Penicillium marneffei is a pathogenic fungus that afflicts immunocompromised individuals having lived or traveled in Southeast Asia. This species is unique in that it is the only dimorphic member of the genus. Dimorphism results from a process, termed phase transition, which is regulated by temperature of incubation. At room temperature, the fungus grows filamentously (mould phase), but at body temperature (37&#176;C), a uninucleate yeast form develops that reproduces by fission. Formation of the yeast phase appears to be a requisite for pathogenicity. To date, no genes have been identified in P. marneffei that strictly induce mould-to-yeast phase conversion. In an effort to help identify potential gene products associated with morphogenesis, protein profiles were generated from the yeast and mould phases of P. marneffei.
Results:
Whole cell proteins from the early stages of mould and yeast development in P. marneffei were resolved by two-dimensional gel electrophoresis. Selected proteins were recovered and sequenced by capillary-liquid chromatography-nanospray tandem mass spectrometry. Putative identifications were derived by searching available databases for homologous fungal sequences. Proteins found common to both mould and yeast phases included the signal transduction proteins cyclophilin and a RACK1-like ortholog, as well as those related to general metabolism, energy production, and protection from oxygen radicals. Many of the mould-specific proteins identified possessed similar functions. By comparison, proteins exhibiting increased expression during development of the parasitic yeast phase comprised those involved in heat-shock responses, general metabolism, and cell-wall biosynthesis, as well as a small GTPase that regulates nuclear membrane transport and mitotic processes in fungi. The cognate gene encoding the latter protein, designated RanA, was subsequently cloned and characterized. The P. marneffei RanA protein sequence, which contained the signature motif of Ran-GTPases, exhibited 90% homology to homologous Aspergillus proteins.
Conclusion:
This study clearly demonstrates the utility of proteomic approaches to studying dimorphism in P. marneffei. Moreover, this strategy complements and extends current genetic methodologies directed towards understanding the molecular mechanisms of phase transition. Finally, the documented increased levels of RanA expression suggest that cellular development in this fungus involves additional signaling mechanisms than have been previously described in P. marneffei.</description>
			<link>http://www.proteomesci.com/content/6/1/17</link>
			
			 	<dc:creator>Julie M Chandler, Erin R Treece, Heather R Trenary, Jessica L Brenneman, Tressa J Flickner, Jonathan L Frommelt, Zaw M Oo, Megan M Patterson, William T Rundle, Olga V Valle, Thomas D Kim, Gary R Walker and Chester R Cooper</dc:creator>
			
			<dc:source>Proteome Science 2008, 6:17</dc:source>
			<dc:date>2008-06-04</dc:date>
			<dc:identifier>doi:10.1186/1477-5956-6-17</dc:identifier>
			
			
							
					<prism:publicationName>Proteome Science</prism:publicationName>
					
			
							
					<prism:issn>1477-5956</prism:issn>
					
			
							
					<prism:volume>6</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-06-04</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
